Jammu Journal

Sjogren’s Syndrome Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

 Breaking News
  • No posts were found

Sjogren’s Syndrome Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

July 02
19:10 2021
Sjogren's Syndrome Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Sjogren’s Syndrome Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Sjogren’s Syndrome Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Sjogren’s syndrome (SS) is a chronic autoimmune rheumatic disease with a specific predisposition for causing inflammation of the exocrine glands, predominantly the salivary and lacrimal glands, including the nose, upper respiratory tract, oropharynx, and the vagina in women. The immune system inappropriately attacks various cells that leads to activation of the various pathway, which results in inflammation.

Despite its considerable prevalence, SS has been devoted much less research interest, time, and effort compared with other close conditions. Various multicenter consortiums initiatives have increased awareness for SS leading to defining key areas of development, ultimately leading to improved patient care.

Get FREE sample copy at: https://www.delveinsight.com/sample-request/sjogrens-syndrome-market-size

The Sjogren’s Syndrome Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Sjogren’s Syndrome market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Sjogren’s Syndrome treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Sjogren’s Syndrome Market Key Facts

  • As per DelveInsight estimates, the total cases of Sjogren’s syndrome (SS) in the 7MM were found to be 3,233,878 in 2020. Among all the countries, the United States accounts for a higher population of Sjogren’s syndrome (SS) with 1,731,780 cases in 2020.

  • Among the EU5 countries, UK had the highest diagnosed prevalent population of Sjögren’s syndrome followed by Germany. On the other hand, Spain had the lowest prevalent population.

  • As per DelveInsight estimates, among the 7MM, Japan had the lowest diagnosed prevalent population of Sjögren’s syndrome in 2020 I.e., 60,481.

  • Females are more prone to SS than males in all countries. In 2020, there were 173,178 prevalent cases of Sjögren’s syndrome in males and 1,558,602 prevalent cases in females in the US and as per analysts’ assessments, the overall cases of SS in both the genders is subjected to increase in the coming years with increasing population.

  • Among the severity-specific cases, most belong to mild cases followed by moderate to severe cases.

Sjogren’s Syndrome Market 

As per DelveInsight assessments, the market size of Sjogren’s syndrome (SS) in the 7MM was found to USD 1,731.8 Million in 2020, for the study period, 2018–2030. Among 7MM, the United States accounts for the highest market size of Sjogren’s syndrome in comparison with EU5 and Japan. In EU5, the market size of SS in the UK was the highest in 2020, while Spain had the lowest market size of Sjögren’s syndrome. However, the market size of SS in Japan was found to lowest as compared to US and EU5.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Sjogren’s Syndrome market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Sjogren’s Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Request for Sample @ Sjogren’s Syndrome Therapeutics Market Assessment

The Sjogren’s Syndrome market size is expected to increase during the study period owing to the launch of upcoming therapies in the 7MM.

Sjogren’s Syndrome Epidemiology

The epidemiology section covers insights about the historical and current Sjogren’s Syndrome patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Sjogren’s Syndrome Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Sjogren’s Syndrome market or expected to get launched in the market during the study period. The analysis covers Sjogren’s Syndrome market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Sjogren’s Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Sjogren’s Syndrome market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for Sjogren’s Syndrome emerging therapies.

Several companies are working robustly on developing many new therapies for the treatment of Sjogren’s syndrome. The mid-stage pipeline is crowded, with several potential therapies with the imminent attention of big pharmaceutical companies. As per the DelveInsight, the launch of the emerging therapies is expected to change the therapeutic market dynamics. 

Sjogren’s Syndrome Companies:

  • Roche

  • Novartis

  • Viela Bio

  • Immupharma

  • TearSolutions

  • GlaxoSmithKline

  • Resolve Therapeutics

  • Novartis/MorphoSys

  • Gilead Sciences

  • Bristol Myers Squibb

And others.

Sjogren’s Syndrome Therapies covered in the report include:

  • VIB7734 

  • VAY736

  • Belimumab 

  • RSLV-132

  • CFZ533

  • LOU-064

  • GS-9876

  • Lacripep

  • Abatacept

  • RO5459072

And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Sjogren’s Syndrome Competitive Intelligence Analysis

4. Sjogren’s Syndrome Market Overview at a Glance

5. Sjogren’s Syndrome Disease Background and Overview

6. Sjogren’s Syndrome Patient Journey

7. Sjogren’s Syndrome Epidemiology and Patient Population

8. Sjogren’s Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

9. Sjogren’s Syndrome Unmet Needs

10. Key Endpoints of Sjogren’s Syndrome Treatment

11. Sjogren’s Syndrome Marketed Products

12. Sjogren’s Syndrome Emerging Therapies

13. Sjogren’s Syndrome Seven Major Market Analysis

14. Attribute Analysis

15. Sjogren’s Syndrome Market Outlook (7 major markets)

16. Sjogren’s Syndrome Access and Reimbursement Overview

17. KOL Views on the Sjogren’s Syndrome Market.

18. Sjogren’s Syndrome Market Drivers

19. Sjogren’s Syndrome Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at: https://www.delveinsight.com/sample-request/sjogrens-syndrome-market-size

Latest Reports By DelveInsight
Sjogren’s Syndrome Pipeline Insights
Sjogren’s Syndrome Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Sjogren’s Syndrome market.

Tissue Heart Valves / Cardiovascular Prosthetic Devices Market
DelveInsight’s “Tissue Heart Valves / Cardiovascular Prosthetic Devices Market Insights, Competitive Landscape and Market Forecast – 2025” report delivers an in-depth understanding of Tissue Heart Valves / Cardiovascular Prosthetic Devices and the historical and forecasted Tissue Heart Valves / Cardiovascular Prosthetic Devices market trends in the US, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan. 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/malignant-mesothelioma-market